Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 5, 2024

Accession no.
0001628280-24-050104
Filed
Dec 5, 2024
Trade date
Nov 1-29, 2024
Filing delay
34 daysLate
Rule 10b5-1 plan
Checked

This filing lists 20 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.35K. It was filed 34 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2024Common StockPPurchaseAcquired+380$1.15+$437263,978Direct
Nov 4, 2024Common StockPPurchaseAcquired+245$1.17+$286.65264,223Direct
Nov 5, 2024Common StockPPurchaseAcquired+380$1.20+$456264,603Direct
Nov 6, 2024Common StockPPurchaseAcquired+380$1.20+$456264,983Direct
Nov 7, 2024Common StockPPurchaseAcquired+380$1.17+$444.6265,363Direct
Nov 8, 2024Common StockPPurchaseAcquired+380$1.18+$448.4265,743Direct
Nov 11, 2024Common StockPPurchaseAcquired+380$1.20+$456266,123Direct
Nov 12, 2024Common StockPPurchaseAcquired+380$1.20+$456266,503Direct
Nov 13, 2024Common StockPPurchaseAcquired+380$1.20+$456266,883Direct
Nov 14, 2024Common StockPPurchaseAcquired+380$1.19+$452.2267,263Direct
Nov 15, 2024Common StockPPurchaseAcquired+380$1.17+$444.6267,643Direct
Nov 18, 2024Common StockPPurchaseAcquired+380$1.18+$448.4268,023Direct
Nov 19, 2024Common StockPPurchaseAcquired+380$1.15+$437268,403Direct
Nov 20, 2024Common StockPPurchaseAcquired+427$1.13+$482.51268,830Direct
Nov 21, 2024Common StockPPurchaseAcquired+427$1.09+$465.43269,257Direct
Nov 22, 2024Common StockPPurchaseAcquired+474$1.07+$507.18269,731Direct
Nov 25, 2024Common StockPPurchaseAcquired+474$1.09+$516.66270,205Direct
Nov 26, 2024Common StockPPurchaseAcquired+474$1.11+$526.14270,679Direct
Nov 27, 2024Common StockPPurchaseAcquired+474$1.15+$545.1271,153Direct
Nov 29, 2024Common StockPPurchaseAcquired+474$1.32+$625.68271,627Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)